Track topics on Twitter Track topics that are important to you
Committed to cure by discovering and developing innovative drugs for the treatment of patients suffering from some forms of cancer, endocrinian disorders and infectious diseases, this is our mission. Therefore, our dedicated and motivated staff is committed to the pursuit of our excellence program based on performance, quality and integrity towards patients and the healthcare community, as well as to our shareholders to secure them with an optimum return in light of their trust towards our work. Products on the market Æterna Zentaris Inc., the "Company" formed following the acquisition of German-based company Zentaris by Æterna Laboratories Inc., benefits from significant added credibility in regard to the development of targeted therapies. The research and development teams have proven their abilities as experts at gearing the development of compounds to precise strategic targets. This track record has succeeded in attracting lucrative partnership and financing agreements at all stages of the development process. Since its beginning, the Company has engaged in the discovery and development of novel drugs culminating with the launch of two products for serious or life-threatening diseases. Products in development In the biopharmaceutical business, risk is best managed through the pursuit and availability of different clinical and preclinical projects. Æterna Zentaris’ pipeline follows a multi-track endeavour in three principal therapeutic fields: oncology, endocrinology and anti-infectives. Besides its proprietary drug discovery unit, the Company’s global scientific network produces a steady stream of innovative new development projects to create breakthrough medicines for patients in need. Growth strategy The Æterna Zentaris business model is to discover and develop innovative products mostly through alliances with pharmaceutical and biotech companies. In case of licensing, the Company reaps revenues from projects even at the earliest stage of development. This latter model minimizes risk through alliance commitments that provide for Æterna Zentaris’ partners to pay most development costs, while Æterna Zentaris retains significant commercial rights.
1405 du Parc-Technologique Blvd
Phone: (418) 652-8525
Fax: (418) 652-0881
The share price of Canada-based Aeterna Zentaris’ had shot up by nearly 200% to $3.01 by Friday lunchtime…
Aeterna Zentaris (WKN: A1439Z) knallt heute unter hohem Umsatz zeitweise über 90% in die Höhe. Das Unternehmen meldete gestern nachbörslich einen PDUFA-Termin für sein Macrilen-Präparat. Die Akti...
Troubled US biotech Aeterna Zentaris has called in outside help to assist with a strategic review after a disastrous few months that saw the company axe its CEO, David Dodd. Things got even worse las...
Thursday, July 20th 2017 at 9:00pm UTC CHARLESTON, S.C.–(BUSINESS WIRE)– Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), announced today that it has formed a special ...
Friday, August 4th 2017 at 9:00pm UTC CHARLESTON, S.C.–(BUSINESS WIRE)– Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”) will announce its second quarter 2017 financial...
Aeterna Zentaris Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Aeterna Zentaris Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment...
The FDA has accepted for review Aeterna Zentaris' resubmitted new-drug application for Macrilen, or macimorelin, indicated fo -More-
Life Sciences Jobs ...
Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and womenâs health. We are eng...
Committed to cure by discovering and developing innovative drugs for the treatment of patients suffering from some forms of cancer, endocrinian disorders and infectious diseases, this is our mission. ...
The Æterna Zentaris group is comprised of healthcare-oriented companies evolving predominantly in the biopharmaceutical as well as personal care industries. Its success depends upon scientific and cl...
Æterna Laboratories Inc. is a biopharmaceutical company focused on the treatment of cancer. The company’s lead product, Neovastat®, is the focus of a number of clinical trials including pivotal tr...
We have published hundreds of AEterna Zentaris news stories on BioPortfolio along with dozens of AEterna Zentaris Clinical Trials and PubMed Articles about AEterna Zentaris for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AEterna Zentaris Companies in our database. You can also find out about relevant AEterna Zentaris Drugs and Medications on this site too.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...